Monoclonal Antibodies In Veterinary Health Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Animal Type, By Application, End-User, By Region, & Competition, 2020-2030F

Description

Global Monoclonal Antibodies In Veterinary Health Market was valued at USD 903.40 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 15.50% through 2030. The global monoclonal antibodies (mAbs) in veterinary health market represents a rapidly growing segment within the broader animal healthcare industry. Monoclonal antibodies, which are lab-engineered antibodies that can target specific antigens, are increasingly being adopted in veterinary medicine for their therapeutic and diagnostic applications.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 903.40 Million
Market Size 2030	USD 2149.29 Million
CAGR 2025-2030	15.50%
Fastest Growing Segment	Dermatology
Largest Market	North America

Key Market Drivers

Increasing Companion Animal Ownership and Pet Humanization

The increasing trend of companion animal ownership, coupled with the growing humanization of pets, is a major driver of the Global Monoclonal Antibodies (mAbs) in the Veterinary Health Market. Over 50% of the global population is estimated to own a pet, with dogs being the most prevalent, found in approximately 33% of households worldwide. Cats are the second most popular choice, owned by nearly 25% of pet-keeping households. This widespread pet ownership trend reflects a significant and growing market opportunity for pet-related industries, including food, healthcare, accessories, and services, driven by increasing consumer demand and the human-animal bond. As pet owners demand higher-quality healthcare solutions for their animals, the market for advanced veterinary therapeutics, including monoclonal antibody-based treatments, is experiencing significant growth.

Households in the U.S., EU, and China collectively own over 500 million dogs and cats, underscoring a massive and expanding market for pet healthcare solutions. In the U.S., pet ownership grew from 68% of households in 2016 to 70% in 2021, reflecting a sustained upward trend in companion animal adoption and increased consumer spending on veterinary care. Over the past decade, there has been a significant increase in pet adoption rates, particularly in developed economies such as North America, Europe, and parts of Asia-Pacific. Factors such as rising disposable incomes, changing lifestyles, and a growing preference for emotional companionship have contributed to this trend. With pet ownership on the rise, there is a corresponding increase in demand for effective veterinary treatments, including monoclonal antibodies for conditions such as arthritis, dermatological disorders, and cancer.

Key Market Challenges

High Development Costs

Developing monoclonal antibodies is a complex and expensive process. Research and development costs can be prohibitively high, which poses a significant challenge for smaller biotech companies and startups looking to enter the market. These high costs can limit the diversity of players and the range of mAb products available..

Key Market Trends

Expansion of Targeted Therapies

One of the most significant upcoming trends is the expansion of targeted therapies using monoclonal antibodies. As our understanding of animal diseases and their molecular mechanisms deepens, researchers are developing mAbs that can target specific disease pathways with precision. This trend promises to provide veterinarians with a broader range of effective treatment options for a variety of conditions.

Key Market Players

Zoetis Inc.
Merck & Co., Inc.
Elanco LLC
Boehringer Ingelheim GmbH
Indian Immunologicals Ltd
Virbac SA

Report Scope:

In this report, the Global Monoclonal Antibodies In Veterinary Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Monoclonal Antibodies In Veterinary Health Market, By Animal Type:

Dogs
Others

Monoclonal Antibodies In Veterinary Health Market, By Application:

Dermatology
Pain
Others

Monoclonal Antibodies In Veterinary Health Market, By End-User:

Veterinary Hospitals
Others

Monoclonal Antibodies In Veterinary Health Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Monoclonal Antibodies In Veterinary Health Market.

Available Customizations:

Global Monoclonal Antibodies In Veterinary Health market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Monoclonal Antibodies In Veterinary Health Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Animal Type (Dogs, Others)
- 5.2.2. By Application (Dermatology, Pain, Others)
- 5.2.3. By End-User (Veterinary Hospitals, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Product Market Map
- 5.3.1. By Animal Type
- 5.3.2. By Application
- 5.3.3. By End-User
- 5.3.4. By Region

6. North America Monoclonal Antibodies In Veterinary Health Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Animal Type (Dogs, Others)
- 6.2.2. By Application (Dermatology, Pain, Others)
- 6.2.3. By End-User (Veterinary Hospitals, Others)
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Monoclonal Antibodies In Veterinary Health Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Animal Type
    - 6.3.1.2.2. By Application
    - 6.3.1.2.3. By End-User
- 6.3.2. Canada Monoclonal Antibodies In Veterinary Health Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Animal Type
    - 6.3.2.2.2. By Application
    - 6.3.2.2.3. By End-User
- 6.3.3. Mexico Monoclonal Antibodies In Veterinary Health Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Animal Type
    - 6.3.3.2.2. By Application
    - 6.3.3.2.3. By End-User

7. Europe Monoclonal Antibodies In Veterinary Health Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Animal Type (Dogs, Others)
- 7.2.2. By Application (Dermatology, Pain, Others)
- 7.2.3. By End-User (Veterinary Hospitals, Others)
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Monoclonal Antibodies In Veterinary Health Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Animal Type
    - 7.3.1.2.2. By Application
    - 7.3.1.2.3. By End-User
- 7.3.2. United Kingdom Monoclonal Antibodies In Veterinary Health Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Animal Type
    - 7.3.2.2.2. By Application
    - 7.3.2.2.3. By End-User
- 7.3.3. France Monoclonal Antibodies In Veterinary Health Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Animal Type
    - 7.3.3.2.2. By Application
    - 7.3.3.2.3. By End-User
- 7.3.4. Italy Monoclonal Antibodies In Veterinary Health Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Animal Type
    - 7.3.4.2.2. By Application
    - 7.3.4.2.3. By End-User
- 7.3.5. Spain Monoclonal Antibodies In Veterinary Health Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Animal Type
    - 7.3.5.2.2. By Application
    - 7.3.5.2.3. By End-User

8. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Animal Type (Dogs, Others)
- 8.2.2. By Application (Dermatology, Pain, Others)
- 8.2.3. By End-User (Veterinary Hospitals, Others)
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Monoclonal Antibodies In Veterinary Health Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Animal Type
    - 8.3.1.2.2. By Application
    - 8.3.1.2.3. By End-User
- 8.3.2. Japan Monoclonal Antibodies In Veterinary Health Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Animal Type
    - 8.3.2.2.2. By Application
    - 8.3.2.2.3. By End-User
- 8.3.3. India Monoclonal Antibodies In Veterinary Health Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Animal Type
    - 8.3.3.2.2. By Application
    - 8.3.3.2.3. By End-User
- 8.3.4. Australia Monoclonal Antibodies In Veterinary Health Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Animal Type
    - 8.3.4.2.2. By Application
    - 8.3.4.2.3. By End-User
- 8.3.5. South Korea Monoclonal Antibodies In Veterinary Health Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Animal Type
    - 8.3.5.2.2. By Application
    - 8.3.5.2.3. By End-User

9. South America Monoclonal Antibodies In Veterinary Health Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Animal Type (Dogs, Others)
- 9.2.2. By Application (Dermatology, Pain, Others)
- 9.2.3. By End-User (Veterinary Hospitals, Others)
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Monoclonal Antibodies In Veterinary Health Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Animal Type
    - 9.3.1.2.2. By Application
    - 9.3.1.2.3. By End-User
- 9.3.2. Argentina Monoclonal Antibodies In Veterinary Health Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Animal Type
    - 9.3.2.2.2. By Application
    - 9.3.2.2.3. By End-User
- 9.3.3. Colombia Monoclonal Antibodies In Veterinary Health Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Animal Type
    - 9.3.3.2.2. By Application
    - 9.3.3.2.3. By End-User

10. Middle East and Africa Monoclonal Antibodies In Veterinary Health Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Animal Type (Dogs, Others)
- 10.2.2. By Application (Dermatology, Pain, Others)
- 10.2.3. By End-User (Veterinary Hospitals, Others)
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Monoclonal Antibodies In Veterinary Health Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Animal Type
    - 10.3.1.2.2. By Application
    - 10.3.1.2.3. By End-User
- 10.3.2. Saudi Arabia Monoclonal Antibodies In Veterinary Health Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Animal Type
    - 10.3.2.2.2. By Application
    - 10.3.2.2.3. By End-User
- 10.3.3. UAE Monoclonal Antibodies In Veterinary Health Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Animal Type
    - 10.3.3.2.2. By Application
    - 10.3.3.2.3. By End-User
- 10.3.4. Kuwait Monoclonal Antibodies In Veterinary Health Market Outlook
  - 10.3.4.1. Market Size & Forecast
    - 10.3.4.1.1. By Value
  - 10.3.4.2. Market Share & Forecast
    - 10.3.4.2.1. By Animal Type
    - 10.3.4.2.2. By Application
    - 10.3.4.2.3. By End-User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Zoetis Inc.
- 14.1.1. Business Overview
- 14.1.2. Product & Service Offering
- 14.1.3. Recent Developments
- 14.1.4. Financials (as reported)
- 14.1.5. Key Personnel
- 14.1.6. SWOT Analysis
14.2. Merck & Co., Inc.
14.3. Elanco LLC
14.4. Boehringer Ingelheim GmbH
14.5. Indian Immunologicals Ltd
14.6. Virbac SA